Search research articles
Contact Us
Filters
Showing results (211-220 of 237) with videos related to
Page
of 24
Sort By:
Journal for Immunotherapy of Cancer
|
July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
Nature Cardiovascular Research
|
September 2, 2022
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
LouJin Song, Ramsey Bekdash, Kumi Morikawa, et al.
Science Translational Medicine
|
March 28, 2020
Noninvasive localization of cardiac arrhythmias using electromechanical wave imaging
Christopher S Grubb, Lea Melki, Daniel Y Wang, et al.
Frontiers in Immunology
|
December 1, 2025
Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers
Joseph T Agnes, Sarah A Marcus, Sahem S Al-Ghraibeh, et al.
Science Translational Medicine
|
October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses
Mark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Molecular Cell
|
March 21, 2024
ERMA (TMEM94) is a P-type ATPase transporter for Mg<sup>2+</sup> uptake in the endoplasmic reticulum
Neelanjan Vishnu, Manigandan Venkatesan, Travis R Madaris, et al.
Molecular Therapy Oncolytics
|
January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
The Journal of Infectious Diseases
|
March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Pablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
Jeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Charu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 237) with videos related to
Sort By:
Page
of 24
Journal for Immunotherapy of Cancer
|
July 7, 2021
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Robert H Vonderheide, Kimberly A Kraynyak, Anthony F Shields, et al.
Nature Cardiovascular Research
|
September 2, 2022
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
LouJin Song, Ramsey Bekdash, Kumi Morikawa, et al.
Science Translational Medicine
|
March 28, 2020
Noninvasive localization of cardiac arrhythmias using electromechanical wave imaging
Christopher S Grubb, Lea Melki, Daniel Y Wang, et al.
Frontiers in Immunology
|
December 1, 2025
Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers
Joseph T Agnes, Sarah A Marcus, Sahem S Al-Ghraibeh, et al.
Science Translational Medicine
|
October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses
Mark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Molecular Cell
|
March 21, 2024
ERMA (TMEM94) is a P-type ATPase transporter for Mg<sup>2+</sup> uptake in the endoplasmic reticulum
Neelanjan Vishnu, Manigandan Venkatesan, Travis R Madaris, et al.
Molecular Therapy Oncolytics
|
January 6, 2017
Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, et al.
The Journal of Infectious Diseases
|
March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Pablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
Jeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Charu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Page
of 24